Skip to main content
Journal cover image

Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions.

Publication ,  Journal Article
Aminsharifi, A; Polascik, TJ
Published in: Eur Urol Oncol
September 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur Urol Oncol

DOI

EISSN

2588-9311

Publication Date

September 2019

Volume

2

Issue

5

Start / End Page

539 / 540

Location

Netherlands

Related Subject Headings

  • Salvage Therapy
  • Prostatic Neoplasms
  • Neoplasm Recurrence, Local
  • Male
  • Humans
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Aminsharifi, A., & Polascik, T. J. (2019). Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions. Eur Urol Oncol, 2(5), 539–540. https://doi.org/10.1016/j.euo.2019.07.008
Aminsharifi, Alireza, and Thomas J. Polascik. “Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions.Eur Urol Oncol 2, no. 5 (September 2019): 539–40. https://doi.org/10.1016/j.euo.2019.07.008.
Aminsharifi A, Polascik TJ. Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions. Eur Urol Oncol. 2019 Sep;2(5):539–40.
Aminsharifi, Alireza, and Thomas J. Polascik. “Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions.Eur Urol Oncol, vol. 2, no. 5, Sept. 2019, pp. 539–40. Pubmed, doi:10.1016/j.euo.2019.07.008.
Aminsharifi A, Polascik TJ. Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions. Eur Urol Oncol. 2019 Sep;2(5):539–540.
Journal cover image

Published In

Eur Urol Oncol

DOI

EISSN

2588-9311

Publication Date

September 2019

Volume

2

Issue

5

Start / End Page

539 / 540

Location

Netherlands

Related Subject Headings

  • Salvage Therapy
  • Prostatic Neoplasms
  • Neoplasm Recurrence, Local
  • Male
  • Humans
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences